First Header Logo Second Header Logo

Connection

Steven Park to Adenine

This is a "connection" page, showing publications Steven Park has written about Adenine.
Connection Strength

1.538
  1. Moore DC, Soni AC, Hu B, Smith ET, Levine J, Moyo TK, Jacobs R, Ghosh N, Park SI. Rituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type. Br J Haematol. 2022 Feb; 196(4):e30-e33.
    View in: PubMed
    Score: 0.795
  2. DiSogra KY, Tran T, Arnall JR, Janes A, Moore DC, Park SI. Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia. J Oncol Pharm Pract. 2021 Jul; 27(5):1265-1269.
    View in: PubMed
    Score: 0.744
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.